Cargando…

Colistin Resistance Among Multi-Drug Resistant Gram-Negative Bacterial Isolates From Different Clinical Samples of ICU Patients: Prevalence and Clinical Outcomes

Introduction: Colistin is considered to be the last resort for the management of infections caused by multi-drug resistant (MDR) gram-negative bacilli (GNB). However, in the recent past, there has been a rise in colistin resistance among MDR isolates in clinical settings with no profound data on the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panigrahi, Kumudini, Pathi, Basanti K, Poddar, Nirmala, Sabat, Smaranita, Pradhan, Sujit, Pattnaik, Dipti, Patro, Shubhransu, Praharaj, Ashok K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Infectious Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499824/ https://www.ncbi.nlm.nih.gov/pubmed/36158344 http://dx.doi.org/10.7759/cureus.28317

Ejemplares similares

Comparative Evaluation of Cartridge-Based Abbott ID NOW Test With Probe-Based Real-Time Reverse Transcription Polymerase Chain Reaction Assay for Detection of SARS-CoV-2
por: Pattnaik, Dipti, et al.
Publicado: (2022)

Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol
por: Dickstein, Yaakov, et al.
Publicado: (2016)

Increasing trends of colistin resistance in patients at high-risk of carbapenem-resistant Enterobacteriaceae
por: El-Mahallawy, Hadir A., et al.
Publicado: (2022)

An Unusual Case of the Successful Treatment of Carbapenem-resistant Ventriculitis with Intravenous Colistin
por: Abu Bakar, Azizi, et al.
Publicado: (2020)

Estimating the Economic and Clinical Value of Reducing Antimicrobial Resistance to Three Gram-negative Pathogens in Japan
por: Matsumoto, Tetsuya, et al.
Publicado: (2021)

The Microbial Profile and Resistance Pattern of Pathogens Isolated From Long COVID Pneumonia Patients and Their Correlation to Clinical Outcome: Our Experience From a Tertiary Care Hospital
por: Rao, C Mohan, et al.
Publicado: (2022)

Circumventing colistin resistance by combining colistin and antimicrobial peptides to kill colistin-resistant and multidrug-resistant Gram-negative bacteria
por: Witherell, Kaitlin S., et al.
Publicado: (2020)

Evaluation of different methods for in vitro susceptibility testing of colistin in carbapenem resistant Gram-negative bacilli
por: Rout, Bidyutprava, et al.
Publicado: (2023)

Pathogens Isolated and Their Association With the Long-Term Outcome in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Rao, C Mohan, et al.
Publicado: (2022)

Sulbactam and Colistin Susceptibility Pattern Among Multidrug-Resistant Acinetobacter Isolates From Respiratory Samples
por: Sengupta, Mallika, et al.
Publicado: (2022)

Synergistic Activity of Colistin in Combination With Resveratrol Against Colistin-Resistant Gram-Negative Pathogens
por: Cannatelli, Antonio, et al.
Publicado: (2018)

Synergistic Activity of Colistin Combined With Auranofin Against Colistin-Resistant Gram-Negative Bacteria
por: Feng, Xiaoxuan, et al.
Publicado: (2021)

The Antibacterial Activity of Kaempferol Combined with Colistin against Colistin-Resistant Gram-Negative Bacteria
por: Zhou, Huijing, et al.
Publicado: (2022)

Synergistic Activity of Colistin in Combination with Clofoctol against Colistin Resistant Gram-Negative Pathogens
por: Collalto, Diletta, et al.
Publicado: (2023)

Efficacy and safety of colistin in the treatment of infections in the ICU caused by multidrug-resistant Gram-negative organisms
por: Pavleas, J, et al.
Publicado: (2006)

Analysis of the challenges in implementing guidelines to prevent the spread of multidrug-resistant gram-negatives in Europe
por: Tacconelli, Evelina, et al.
Publicado: (2019)

Naringenin restores colistin activation against colistin-resistant gram-negative bacteria in vitro and in vivo
por: Xu, Mengxin, et al.
Publicado: (2022)

Flufenamic Acid, a Promising Agent for the Sensitization of Colistin-Resistant Gram-Negative Bacteria to Colistin
por: Zhang, Yi, et al.
Publicado: (2023)

Streptococcus agalactiae-Related Splenic Abscess in Uncontrolled Diabetes Mellitus
por: Mallick, Bipadabhanjan, et al.
Publicado: (2020)

Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria in Vitro and in Vivo
por: Zhang, Ying, et al.
Publicado: (2021)

Retrospective observational study to assess the clinical management and outcomes of hospitalised patients with complicated urinary tract infection in countries with high prevalence of multidrug resistant Gram-negative bacteria (RESCUING)
por: Shaw, Evelyn, et al.
Publicado: (2016)

Susceptibility of Colistin-Resistant, Gram-Negative Bacteria to Antimicrobial Peptides and Ceragenins
por: Hashemi, Marjan M., et al.
Publicado: (2017)

Melatonin overcomes MCR-mediated colistin resistance in Gram-negative pathogens
por: Liu, Yuan, et al.
Publicado: (2020)

An Update of Mobile Colistin Resistance in Non-Fermentative Gram-Negative Bacilli
por: Khuntayaporn, Piyatip, et al.
Publicado: (2022)

Early and Appropriate Use of Ceftazidime-Avibactam in the Management of Multidrug-Resistant Gram-Negative Bacterial Infections in the Indian Scenario
por: Swaminathan, Subramanian, et al.
Publicado: (2022)

2433. Evaluation of Meropenem (MEM) in Combination With Colistin (COL) Against Colistin-Resistant Extensively Drug-Resistant (XRD) Gram-Negative Bacteria
por: Singh, Nivedita, et al.
Publicado: (2018)

Colistin monotherapy versus combination of colistin with a β-lactam or rifampicin for the treatment of serious infections in the ICU due to multidrug-resistant Gram-negative bacteria
por: Tsimogianni, A, et al.
Publicado: (2006)

Glycopeptide Resistance in Gram-Positive Cocci: A Review
por: Sujatha, S., et al.
Publicado: (2012)

Disrupting iron homeostasis can potentiate colistin activity and overcome colistin resistance mechanisms in Gram-Negative Bacteria
por: Gadar, Kavita, et al.
Publicado: (2023)

Evidence-Based Interventions to Reduce the Incidence of Common Multidrug-Resistant Gram-Negative Bacteria in an Adult Intensive Care Unit
por: Althaqafi, Abdulhakeem, et al.
Publicado: (2023)

Parenteral colistin for the treatment of severe infections by multidrug-resistant Gram-negative bacteria
por: Grion, C, et al.
Publicado: (2013)

Membrane permeabilization of colistin toward pan-drug resistant Gram-negative isolates()
por: Mohamed, Yasmine Fathy, et al.
Publicado: (2016)

Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance
por: Stokes, Jonathan M., et al.
Publicado: (2017)

Colistin resistance in non-fermenting Gram-negative bacilli in a university hospital
por: Santos, Silvana Oliveira dos, et al.
Publicado: (2016)

Resensitizing multidrug-resistant Gram-negative bacteria to carbapenems and colistin using disulfiram
por: Chen, Chen, et al.
Publicado: (2023)

Synergistic Activity and Biofilm Formation Effect of Colistin Combined with PFK-158 Against Colistin-Resistant Gram-Negative Bacteria
por: Chen, Liqiong, et al.
Publicado: (2021)

High Prevalence of Antibiotic-Resistant Gram-Negative Bacteria Causing Surgical Site Infection in a Tertiary Care Hospital of Northeast India
por: Deka, Sangeeta, et al.
Publicado: (2020)

Assessing the Effectiveness of Antibiotic Therapy Against Common Gram-Negative Bacteria in a Saudi Arabian Hospital Using the Drug Resistance Index
por: Yaseen, Muhammad, et al.
Publicado: (2022)

Risk Factors for Infection With Multidrug-Resistant Gram-Negative Bacteria in a Tertiary Care Hospital in Saudi Arabia: A Case-Control Study
por: Althaqafi, Abdulhakeem, et al.
Publicado: (2023)

Combination Regimens with Colistin Sulfate versus Colistin Sulfate Monotherapy in the Treatment of Infections Caused by Carbapenem-Resistant Gram-Negative Bacilli
por: Hao, Min, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qj9d6ds1qgaim4u9ps8vj82oec